Vaishali Pharma Ltd

NEW
NSE:VAISHALI (India)  
₹ 19.39 (-2.02%) Dec 10
On watch
549.77
P/B:
3.81
Market Cap:
₹ 2.53B ($ 29.83M)
Enterprise V:
₹ 2.37B ($ 27.91M)
Volume:
10.81K
Avg Vol (2M):
819.14K
Warning! GuruFocus detected 2 Medium warning signs with VAISHALI. Try a 7-Day Free Trial to check it out.
Trade In:
Volume:
10.81K
Market Cap ₹:
2.53B
Market Cap $:
29.83M
549.77
Avg Vol (2M):
819.14K
Enterprise Value ₹:
2.37B
Enterprise Value $:
27.91M
PB Ratio:
3.81
Website Sources Stock PDF
Dataset
Financial Download GuruFocus Premium Icon Manual of Stocksâ„¢

Business Description

Vaishali Pharma Ltd

ISIN : INE972X01022
https://www.vaishalipharma.com
R.C. Patel Road, Off Sodawala Lane, 706-709, 7th Floor, Aravalli Business Center, Borivili (West), Mumbai, MH, IND, 400092
Compare
Compare
BOM:537536BOM:524824BOM:524518BOM:532878NSE:SOTACBOM:531173BOM:532637BOM:540702BOM:531569BOM:524828ZTSXTER:MRKTSE:4502LSE:HLNNSE:SUNPHARMATSE:4523TSE:4507SZSE:000538XSWX:SDZHKSE:03692
Traded in other countries / regions
VAISHALI.India
IPO Date
2017-08-22
Description
Vaishali Pharma Ltd is a pharmaceutical company. The company is engaged in the business of trading pharmaceutical products. The company mainly deals in Active Pharmaceutical ingredients, pharmaceutical formulations, surgical products, and veterinary supplements operating in the domestic and export markets.

Financial Strength

8/10
Name Current Vs Industry Vs History
Cash-To-Debt 2.24
Equity-to-Asset 0.65
Debt-to-Equity 0.19
Debt-to-EBITDA 3.3
Interest Coverage 2.89
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.15
Distress
Grey
Safe
Beneish M-Score -2.19
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

5/10
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 15.8
3-Year EBITDA Growth Rate -6.2
3-Year EPS without NRI Growth Rate 24.1
3-Year FCF Growth Rate -28.3
3-Year Book Growth Rate 23.4

Momentum Rank

3/10
Name Current Vs Industry Vs History
5-Day RSI 67.59
9-Day RSI 66.38
14-Day RSI 60.99
3-1 Month Momentum % -4.72
6-1 Month Momentum % 28.7
12-1 Month Momentum % 11.3

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.98
Quick Ratio 2.93
Cash Ratio 0.89
Days Inventory 4.52
Days Sales Outstanding 193.16
Days Payable 64.8

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.5
Shareholder Yield % 0.6

Profitability Rank

6/10
Name Current Vs Industry Vs History
Gross Margin % 7.51
Operating Margin % 6.49
Net Margin % 1.16
FCF Margin % 0.74
ROE % 2.12
ROA % 1.25
ROIC % 8.86
3-Year ROIIC % 12.3
ROC (Joel Greenblatt) % 8.06
ROCE % 6.22
Years of Profitability over Past 10-Year 9

GF Value Rank

10/10
Name Current Vs Industry Vs History
PE Ratio 549.77
PE Ratio without NRI 51.67
Shiller PE Ratio 130.58
PEG Ratio 4.1
PS Ratio 2.42
PB Ratio 3.81
Price-to-Tangible-Book 3.79
Price-to-Free-Cash-Flow 299.87
Price-to-Operating-Cash-Flow 260.42
EV-to-EBIT 68.24
EV-to-EBITDA 59.55
EV-to-Revenue 2.5
EV-to-FCF 355.49
Price-to-GF-Value 1.1
Price-to-Projected-FCF 5.72
Price-to-Peter-Lynch-Fair-Value 2.36
Price-to-Graham-Number 2.92
Price-to-Net-Current-Asset-Value 4.06
Earnings Yield (Greenblatt) % 1.46
FCF Yield % 0.27
Forward Rate of Return (Yacktman) % 13.5
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Vaishali Pharma Ltd Executives

Details

GF Value: ₹17.57

NSE:VAISHALI

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ₹) 946.407
EPS (TTM) (₹) 0.036
Beta 0.1
3-Year Sharpe Ratio 1.11
3-Year Sortino Ratio 2.55
Volatility % 48.51
14-Day RSI 60.99
14-Day ATR (₹) 0.949126
20-Day SMA (₹) 17.3795
12-1 Month Momentum % 11.3
52-Week Range (₹) 12.49 - 24.91
Shares Outstanding (Mil) 130.46

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Vaishali Pharma Ltd Filings

Filing Date Document Date Form
No Filing Data

Vaishali Pharma Ltd Stock Events

Financials Calendars
Event Date Price (₹)
No Event Data

Vaishali Pharma Ltd Frequently Asked Questions

What is Vaishali Pharma Ltd(NSE:VAISHALI)'s stock price today?
The current price of NSE:VAISHALI is ₹19.39. The 52 week high of NSE:VAISHALI is ₹24.91 and 52 week low is ₹12.49.
When is next earnings date of Vaishali Pharma Ltd(NSE:VAISHALI)?
The next earnings date of Vaishali Pharma Ltd(NSE:VAISHALI) is .
Does Vaishali Pharma Ltd(NSE:VAISHALI) pay dividends? If so, how much?
Vaishali Pharma Ltd(NSE:VAISHALI) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.